Literature DB >> 25605839

Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?

Miguel Melo1, Adriana Gaspar da Rocha2, João Vinagre3, Manuel Sobrinho-Simões4, Paula Soares5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25605839     DOI： 10.1200/JCO.2014.59.4614

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

1.  Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.

Authors:  Joseph R Osborne; Jessica D Kondraciuk; Samuel L Rice; Xiaosun Zhou; Andrea Knezevic; Daniel E Spratt; Mona Sabra; Steven M Larson; Ravinder K Grewal
Journal:  Clin Nucl Med       Date:  2019-07       Impact factor: 7.794

Review 2.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

3.  Thyroid Cancer Bone Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.

Authors:  Jessica D Kondraciuk; Samuel L Rice; Xiaosun Zhou; Karem Gharzeddine; Andrea Knezevic; Daniel E Spratt; Mona Sabra; Steven M Larson; Ravinder K Grewal; Joseph R Osborne
Journal:  Clin Nucl Med       Date:  2019-08       Impact factor: 7.794

4.  Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.

Authors:  Semen Onder; Sule Ozturk Sari; Gulcin Yegen; Ismail Cem Sormaz; Ismail Yilmaz; Sukran Poyrazoglu; Yasemin Sanlı; Yasemin Giles Senyurek; Yersu Kapran; Ozgur Mete
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

5.  Downregulation of cyclin-dependent kinase 8 by microRNA-148a suppresses proliferation and invasiveness of papillary thyroid carcinomas.

Authors:  Chun Han; Weihui Zheng; Minghua Ge; Kejing Wang; Yangfeng Xiang; Peng Wang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

6.  TERT Genetic Mutations as Prognostic Marker in Glioma.

Authors:  Peiliang Geng; Xiaoxin Zhao; Juanjuan Ou; Jianjun Li; Rina Sa; Houjie Liang
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

7.  Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group.

Authors:  Keith C Bible; Gilbert J Cote; Michael J Demeure; Rossella Elisei; Sissy Jhiang; Matthew D Ringel
Journal:  J Clin Endocrinol Metab       Date:  2015-09-29       Impact factor: 5.958

8.  GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.

Authors:  Xiaotian Yuan; Ninni Mu; Na Wang; Klas Strååt; Anastasios Sofiadis; Yanxia Guo; Adam Stenman; Kailin Li; Guanghui Cheng; Lu Zhang; Feng Kong; Lars Ekblad; Johan Wennerberg; Inga-Lena Nilsson; C Christofer Juhlin; Catharina Larsson; Dawei Xu
Journal:  Oncogene       Date:  2018-09-04       Impact factor: 9.867

Review 9.  Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications.

Authors:  Tiantian Liu; Xiaotian Yuan; Dawei Xu
Journal:  Genes (Basel)       Date:  2016-07-18       Impact factor: 4.096

10.  Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis.

Authors:  Xingyun Su; Xiaoxia Jiang; Weibin Wang; Haiyong Wang; Xin Xu; Aihui Lin; Xiaodong Teng; Huiling Wu; Lisong Teng
Journal:  Onco Targets Ther       Date:  2016-11-11       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.